Table 3.
Promoter methylation status, expression levels and localizations of Secreted Frizzled Related Protein 4 (SFRP4) protein in astrocytoma samples and patients’ survival.
| Patient no | SFRP4 methylation | SFRP4 expression | Localization | Survival (months) |
|---|---|---|---|---|
| 1 | U | 2 | C | 103 |
| 2 | M | 2 | C + M + N | 61 |
| 3 | M | 1 | C | 71 |
| 4 | U | 1 | C + M + N | 105 |
| 5 | U | 1 | C | 129 |
| 6 | M | 3 | C + M + N | 42 |
| 7 | M | 3 | C + M + N | 20 |
| 8 | M | ND | ND | 79 |
| 9 | M | 2 | C + M | ND |
| 10 | M | 1 | C + M + N | ND |
| 11 | M | 2 | C + M | ND |
| 12 | U | 1 | C | ND |
| 13 | ND | 1 | C + M + N | 4 |
| 14 | U | 2 | C + M + N | 83 |
| 15 | U | 1 | C + M + N | 55 |
| 16 | U | 1 | C + M + N | 100 |
| 17 | U | 2 | C + M + N | 14 |
| 18 | U | 1 | C | ND |
| 19 | U | 2 | C | ND |
| 20 | U | 3 | C + M | ND |
| 21 | U | 1 | C + M + N | ND |
| 22 | U | 1 | C + M | 7 |
| 23 | U | 1 | C | 10 |
| 24 | U | 2 | C | 18 |
| 25 | U | 1 | C + M + N | 26 |
| 26 | U | 1 | 0 | 10 |
| 27 | U | 1 | C | 25 |
| 28 | U | 1 | C | 47 |
| 29 | U | 1 | 0 | 81 |
| 30 | U | 1 | C | 11 |
| 31 | U | 1 | C | ND |
| 32 | U | 1 | C | 48 |
| 33 | U | 1 | C | 19 |
| 34 | U | 1 | C + M | 5 |
| 35 | U | 2 | C + M | 13 |
| 36 | U | 1 | C | 33 |
| 37 | U | 1 | C + M + N | 6 |
| 38 | U | 2 | C + M + N | 97 |
| 39 | U | 1 | C | 10 |
| 40 | U | 1 | C + M + N | 41 |
| 41 | U | 1 | C | 25 |
| 42 | U | 1 | C | ND |
| 43 | U | 1 | C | 36 |
| 44 | U | 1 | C + M | 5 |
| 45 | ND | 1 | C + M + N | ND |
| 46 | U | 1 | C | 3 |
| 47 | U | 2 | C | 3 |
| 48 | U | 1 | C | ND |
| 49 | U | 1 | C + N | 10 |
| 50 | U | 1 | C + M + N | 8 |
| 51 | U | 1 | C | 14 |
M, methylated; U, unmethylated; 1, weak or lack of expression; 2, moderate expression; 3, strong expression; C, cytoplasmic; M, membranous; N, nuclear; ND, not determined.